Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

  1. Ascierto, P.A.
  2. Casula, M.
  3. Bulgarelli, J.
  4. Pisano, M.
  5. Piccinini, C.
  6. Piccin, L.
  7. Cossu, A.
  8. Mandalà, M.
  9. Ferrucci, P.F.
  10. Guidoboni, M.
  11. Rutkowski, P.
  12. Ferraresi, V.
  13. Arance, A.
  14. Guida, M.
  15. Maiello, E.
  16. Gogas, H.
  17. Richtig, E.
  18. Fierro, M.T.
  19. Lebbe, C.
  20. Helgadottir, H.
  21. Queirolo, P.
  22. Spagnolo, F.
  23. Tucci, M.
  24. Del Vecchio, M.
  25. Cao, M.G.
  26. Minisini, A.M.
  27. De Placido, S.
  28. Sanmamed, M.F.
  29. Mallardo, D.
  30. Paone, M.
  31. Vitale, M.G.
  32. Melero, I.
  33. Grimaldi, A.M.
  34. Giannarelli, D.
  35. Dummer, R.
  36. Sileni, V.C.
  37. Palmieri, G.
  38. Show all authors +
Journal:
Nature Communications

ISSN: 2041-1723

Year of publication: 2024

Volume: 15

Issue: 1

Type: Article

DOI: 10.1038/S41467-023-44475-6 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus